RU2005129872A -
METHOD FOR TREATING A MUCLEA OF THE HOLE AFTER REMOVING A TOOTH
- Google Patents
METHOD FOR TREATING A MUCLEA OF THE HOLE AFTER REMOVING A TOOTH
Download PDF
Info
Publication number
RU2005129872A
RU2005129872ARU2005129872/14ARU2005129872ARU2005129872ARU 2005129872 ARU2005129872 ARU 2005129872ARU 2005129872/14 ARU2005129872/14 ARU 2005129872/14ARU 2005129872 ARU2005129872 ARU 2005129872ARU 2005129872 ARU2005129872 ARU 2005129872A
Казанский государственный медицинский университет(RU)
Казанский государственный медицинский университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Казанский государственный медицинский университет(RU), Казанский государственный медицинский университетfiledCriticalКазанский государственный медицинский университет(RU)
Priority to RU2005129872/14ApriorityCriticalpatent/RU2304956C2/en
Publication of RU2005129872ApublicationCriticalpatent/RU2005129872A/en
Application grantedgrantedCritical
Publication of RU2304956C2publicationCriticalpatent/RU2304956C2/en
Dental Tools And Instruments Or Auxiliary Dental Instruments
(AREA)
Claims (1)
Способ лечения слизистой оболочки лунки после удаления зуба, включающий медикаментозную терапию, отличающийся тем, что проводят аэроионотерапию в течение 7-10 мин на лунку удаленного зуба с помощью специального тубуса, присоединяющегося к аппарату "Гиппократ-медицина".A method of treating a mucous membrane of a hole after tooth extraction, including drug therapy, characterized in that aeroionotherapy is carried out for 7-10 minutes per well of a removed tooth using a special tube connecting to the Hippocrates Medicine apparatus.
RU2005129872/14A2005-09-262005-09-26Method for treating alveolar socket mucous membrane after tooth extraction
RU2304956C2
(en)
An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism